Delfi News

Is There An Opportunity With Delfi Limited's (SGX:P34) 42% Undervaluation?

Yahoo FinanceMay 6 12:26

Delfi (SGX:P34) Has Announced A Dividend Of $0.0302

Yahoo FinanceApr 20 06:50

Delfi (SGX:P34) Strong Profits May Be Masking Some Underlying Issues

Delfi Limited's (SGX:P34) robust recent earnings didn't do much to move the stock. We think this is due to investors looking beyond the statutory profits and being concerned with what they see. SG

Simply Wall StApr 13 06:43

Delfi's Earnings Margins May Face Minimal Pressure From High Cocoa Prices -- Market Talk

0713 GMT - Delfi's earnings margins may face minimal pressure from high prices of its key ingredient cocoa, RHB Research analyst Alfie Yeo says in a research report. The Singapore-listed chocolate con

WSJApr 11 15:13

Delfi (SGX:P34) Is Due To Pay A Dividend Of $0.0302

Yahoo FinanceApr 6 06:38

Delfi Limited Announces Board Leadership Transition

TipRanksApr 5 18:47

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics) FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. Firs

PR NewswireApr 1 21:00

Delfi Faces Earnings Hit From Higher Raw Material Prices -- Market Talk

0415 GMT - Delfi faces an earnings hit from higher raw material prices, RHB Research analyst Alfie Yeo says, noting that the Singapore-listed company's 2023 revenue growth and operating margins missed

WSJMar 19 12:15

Delfi Ltd. Target Price Lowered to S$1.33 From S$1.55 by RHB Research >P34.SG

Delfi Ltd. Target Price Lowered to S$1.33 From S$1.55 by RHB Research >P34.SG

Dow JonesMar 19 11:18

Shareholders in Delfi (SGX:P34) Are in the Red If They Invested Five Years Ago

Yahoo FinanceMar 18 14:22

Delfi Faces Earnings Hit From Higher Commodity Prices -- Market Talk

0212 GMT - Delfi faces earnings hit from higher commodity prices, UOB Kay Hian analysts say in a research note as they lower the stock's rating to hold from buy and cut the target to S$1.07 from S$1.7

WSJMar 6 10:12

Delfi Cut to Hold From Buy by UOB Kay Hian >P34.SG

Delfi Cut to Hold From Buy by UOB Kay Hian >P34.SG

Dow JonesMar 6 09:58

Delfi Limited's (SGX:P34) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Delfi (SGX:P34) has had a rough three months with its share price down 18%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-

Simply Wall StMar 5 06:12

CGS International Adjusts Delfi's Price Target to SG$1.47 From SG$1.56, Keeps at Add

10:48 PM EST, 03/03/2024 (MT Newswires) -- CGS International Adjusts Delfi's Price Target to SG$1.47 From SG$1.56, Keeps at Add Price (SGD): S$0.96, Change: S$-0.01, Percent Change: -1.04%

MT NewswiresMar 4 11:48

Delfi (SGX:P34) Will Pay A Dividend Of $0.0302

Yahoo FinanceMar 2 06:43

Delfi Limited: A Sweet Opportunity for Investors Amidst Market Leadership and Strategic Growth

TipRanksMar 1 16:38

Delfi Full Year 2023 Earnings: EPS: US$0.076 (Vs US$0.072 in FY 2022)

Yahoo FinanceFeb 29 08:37

Delfi's H2 2023 Attributable Profit Slides 14% Amid Increased Costs

Delfi (SGX:P34) saw a more than 14% decline in attributable profit for the second half of 2023 after selling, distribution, and finance costs increased from a year ago. The chocolate company's profit

MT NewswiresFeb 28 10:54

Multi-Cancer Diagnostic Tests Market Outlook 2024-2029, Featuring Profiles of Anchordx Medical, Burning Rock Biotech, Delfi Diagnostics, Exact Sciences, Freenome, Genecast, Grail and Guardant Health

Yahoo FinanceFeb 22 17:17

DELFI Collaborates With Immunocore Holdings For Exploring Use Of DELFI-TF Cancer Monitoring Assay

DELFI Collaborates With Immunocore Holdings For Exploring Use Of DELFI-TF Cancer Monitoring Assay

BenzingaFeb 1 22:11